Clinical trial
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host…
NCT00074035 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00074035 |
|---|---|
| Title | Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease |
| Official title | A Phase II Trial Of Intravenous Pentostatin For The Treatment Of Patients With Refractory Chronic Graft-Versus-Host Disease |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | pentostatin |
| Enrollment | 39 |
| Start date | Dec 1, 2003 |
| Primary completion | Aug 1, 2008 |
| Completion | Nov 1, 2014 |
| First posted | Dec 11, 2003 |
| Last update posted | Nov 3, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: